65,437 trials
Adult Nasal Type Extranodal NK/T-cell Lymphoma · Anaplastic Large Cell Lymphoma · Angioimmunoblastic T-cell Lymphoma
Primary: Objective Response Rate (ORR) — 2; 6 Participants
Healthy Japanese Young and Elderly Male and Non-fertile Female Volunteers
Primary: Safety - Adverse Events — 1; 1; 0; 2 Participants
Kidney Diseases
Primary: Stimulation of Growth After 12 Months (Delta Z-score) — 1.2; 0.6 units on a scale
Fallopian Tube Cancer · Primary Peritoneal Serous Adenocarcinoma · Recurrent Ovarian Epithelial Cancer
Primary: Clinical Response Benefit (Modified Gynecologic Cancer InterGroup [GCIG] Cancer Antigen [CA]-125 Response or Stable Disease) Based on the Response Evaluation Criteria in…
Solid Tumours
Primary: Change From Baseline in QTcF — 2.0; -4.1; -4.2 msec
Hyperlipidemia
Primary: Change From Baseline in Lipid Profile — 4.20; 3.37; -0.06 mg/dl
Contraception
Primary: Rates of Uterine Perforation — 0 Number of cases
Meningitis, Epiglottitis, Pneumonia, Arthritis Caused by Haemophilus Influenzae Type b
Primary: Geometric Mean Anti-PRP (Polyribosyl Ribitol Phosphate) Concentrations at Day 1 (4 Years Post Booster Dose Administered in Study V37_07E1) — 2.66; 5.05 Concentration in…
Complicated Skin and Soft Tissue Infection
Primary: Clinical Response at Test of Cure (TOC) in Modified Intent-to-treat (MITT) Analysis Set — 396; 202; 58; 34 Participant
Atherosclerosis · Cardiovascular Disease
Primary: Changes in Plaque Architecture and Composition Directly Measured by Magnetic Resonance Imaging (MRI) in the Aorta and Carotid Arteries — 7; 5 percentage of internal…
Duchenne Muscular Dystrophy
Primary: Change in the Number (%) of Dystrophin Positive Fibers — 23; -7.48; 0.79; -0.63 percentage of dystrophin Pos. fibers
Glaucoma, Open-Angle · Ocular Hypertension
Primary: Change From Baseline in Mean Worse Eye Intraocular Pressure (IOP) Analyzed by Two-Sample T-Test — 25.42; 24.43; -10.45; -8.28 Millimeters of Mercury (mmHg)
Common Cold
Primary: Reducing Symptoms of a Common Cold — 53; 53; 55; 54 units on a scale
Chronic Hepatitis C
Primary: Percentage of Participants With Sustained Virologic Response (SVR) 12 Weeks After Discontinuation of Therapy (SVR12) — 71.9; 77.5; 82.6 percentage of participants
Heart Failure
Primary: Change in Peak VO2 (Oxygen Consumption ) — 1.21; 0.48 ml/kg/min